Opposing effects on immune function and skin barrier regulation by the proteasome inhibitor bortezomib in an allergen-induced eczema model

Experimental Dermatology

Volumn 22, Issue 11, 2013, Pages 742-747

  Mudnakudu Nagaraju, Kiran Kumar ^a   Babina, Magda ^a   Worm, Margitta ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antibody secreting cells; Atopic dermatitis; Bortezomib (Velcade ); Proteasome inhibition; Skin barrier

Indexed keywords

BORTEZOMIB; IMMUNOGLOBULIN E;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HOMING; CONTROLLED STUDY; ECZEMA; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOHISTOLOGY; IMMUNOMODULATION; MOUSE; NONHUMAN; PLASMA CELL; SKIN ALLERGY; SKIN PERMEABILITY;

ANTIBODY-SECRETING CELLS; ATOPIC DERMATITIS; BORTEZOMIB (VELCADE®); PROTEASOME INHIBITION; SKIN BARRIER;

ANIMALS; BORONIC ACIDS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ECZEMA; FEMALE; IMMUNE SYSTEM; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED BALB C; ORGAN CULTURE TECHNIQUES; PROTEASOME INHIBITORS; PYRAZINES; SKIN;

EID: 84886790879     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12261     Document Type: Article

References (53)

1. Nencioni A, Grünebach F, Patrone F et al. Leukemia 2007: 21: 30-36.
2. Dantuma N P, Lindsten K. Cardiovasc Res 2010: 85: 263-271.
3. Kim R, Emi M, Tanabe K et al. Apoptosis 2006: 11: 5-13.
4. Obeng E A, Carlson L M, Gutman D M et al. Blood 2006: 107: 4907-4916.
5. Chauhan D, Hideshima T, Mitsiades C et al. Mol Cancer Ther 2005: 4: 686-692.
6. Mateos M V, San Miguel J F. Best Pract Res Clin Haematol 2007: 20: 701-715.
7. Levêque D, Carvalho M C, Maloisel F. In Vivo 2007: 21: 273-278.
8. Mujtaba T, Dou Q P. Discov Med 2011: 12: 471-480.
9. Cenci S, Oliva L, Cerruti F et al. J Leukoc Biol 2012: 92: 921-931.
10. Cenci S, Mezghrani A, Cascio P et al. EMBO J 2006: 25: 1104-1113.
11. Neubert K, Meister S, Moser K et al. Nat Med 2008: 14: 748-755.
12. Lee S W, Kim J H, Park Y B et al. Ann Rheum Dis 2009: 68: 1761-1767.
13. Gomez A M, Vrolix K, Martínez-Martínez P et al. J Immunol 2011: 186: 2503-2513.
14. Wegmann M, Lunding L, Orinska Z et al. Int Arch Allergy Immunol 2012: 158: 43-53.
15. Dahten A, Koch C, Ernst D et al. J Invest Dermatol 2008: 128: 2211-2218.
16. Hartmann B, Riedel R, Jörss K et al. J Invest Dermatol 2012: 132: 330-336.
17. Hartmann B, Heine G, Babina M et al. Allergy 2011: 66: 540-548.
18. Babina M, Kirn F, Hoser D et al. Clin Exp Allergy 2010: 40: 1256-1265.
19. Yanaba K, Yoshizaki A, Muroi E et al. J Leukoc Biol 2010: 88: 117-122.
20. Bieber T. Ann Dermatol 2010: 22: 125-137.
21. Leung D Y, Boguniewicz M, Howell M D et al. J Clin Invest 2004: 113: 651-657.
22. Woodward A L, Spergel J M, Alenius H et al. J Allergy Clin Immunol 2001: 107: 359-366.
23. Hennino A, Vocanson M, Toussaint Y et al. J Immunol 2007: 178: 5571-5577.
24. Weise C, Ernst D, van Tol E A et al. Pediatr Allergy Immunol 2013: 24: 361-367.
25. Weise C, Zhu Y, Ernst D et al. Exp Dermatol 2011: 20: 805-809.
26. Voigt A, Rahnefeld A, Kloetzel P M et al. Front Physiol 2013: 4: 42.
27. Hideshima T, Richardson P, Chauhan D et al. Cancer Res 2001: 61: 3071-3076.
28. Davenport E L, Moore H E, Dunlop A S et al. Blood 2007: 110: 2641-2649.
29. Neubert K, Meister S, Moser K et al. Nat Med 2008: 14: 748-755.
30. Davies J M, Platts-Mills T A, Aalberse R C. J Allergy Clin Immunol 2013: 131: 972-976.
31. Yoshida T, Mei H, Dörner T et al. Immunol Rev 2010: 237: 117-139.
32. Luger E O, Fokuhl V, Wegmann M et al. J Allergy Clin Immunol 2009: 124: 819-826.
33. Wüthrich B, Schmid-Grendelmeier P. J Investig Allergol Clin Immunol 2003: 13: 1-5.
34. Liu F T, Goodarzi H, Chen H Y. Clin Rev Allergy Immunol 2011: 41: 298-310.
35. Belloni B, Ziai M, Lim A et al. J Allergy Clin Immunol 2007: 120: 1223-1225.
36. Sheinkopf L E, Rafi A W, Do L T et al. Allergy Asthma Proc 2008: 29: 530-537.
37. Heil P M, Maurer D, Klein B et al. J Dtsch Dermatol Ges 2010: 8: 990-998.
38. Saint-Mezard P, Berard F, Dubois B et al. Eur J Dermatol 2004: 14: 131-138.
39. Candi E, Schmidt R, Melino G. Nat Rev Mol Cell Biol 2005: 6: 328-340.
40. Proksch E, Brandner J M, Jensen J M. Exp Dermatol 2008: 17: 1063-1072.
41. Hänel K H, Cornelissen C, Lüscher B et al. Int J Mol Sci 2013: 14: 6720-6745.
42. Gutowska-Owsiak D, Ogg G S. Clin Exp Allergy 2013: 43: 586-598.
43. O'Regan G M, Irvine A D. Clin Exp Allergy 2010: 40: 965-972.
44. Guttman-Yassky E, Suárez-Fariñas M, Chiricozzi A et al. J Allergy Clin Immunol 2009: 124: 1235-1244.
45. Hatano Y, Adachi Y, Elias P M et al. Exp Dermatol 2013: 22: 30-35.
46. Howell M D, Kim B E, Gao P et al. J Allergy Clin Immunol 2007: 120: 150-155.
47. Powell B C, Passmore E A, Nesci A et al. Mech Dev 1998: 78: 189-192.
48. Tung D, Cheung P H, Kaur P et al. Pharmacology 2011: 88: 100-113.
49. Chamcheu J C, Wood G S, Siddiqui I A et al. Exp Dermatol 2012: 21: 481-489.
50. Shen S C, Lee W R, Yang L Y et al. Dermatology 2012: 21: 370-375.
51. Löffek S, Bruckner-Tuderman L, Magin T M. Exp Dermatol 2012: 21: 791-793.
52. Patrizi A, Venturi M, Dika E et al. Cutan Ocul Toxicol 2013: 2. doi:10.3109/15569527.2013.787086 [Epub ahead of print].
53. Van Regenmortel N, Van de Voorde K, De Raeve H et al. Haematologica 2005: 90: 116-117.